| Hilary Szczypiorski, RPH | |
|
40 Pennwood Pl, Suite 300, Warrendale, PA 15086-6512 | |
| (724) 779-4720 | |
| (724) 779-4720 |
| Full Name | Hilary Szczypiorski |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 40 Pennwood Pl, Warrendale, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003253899 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP440262 (Pennsylvania) | Primary |
| 183500000X | Pharmacist | RP10000274 (Pennsylvania) | Secondary |
| 183500000X | Pharmacist | 37329 (Tennessee) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Hilary Szczypiorski, RPH 40 Pennwood Pl, Suite 300, Warrendale, PA 15086-6512 Ph: (724) 779-4720 | Hilary Szczypiorski, RPH 40 Pennwood Pl, Suite 300, Warrendale, PA 15086-6512 Ph: (724) 779-4720 |
News Archive
​High-resolution mapping of the epigenome has discovered unique patterns that emerge during the generation of brain circuitry in childhood.
When a coronary artery is obstructed by atheroma, blood flow is depressed or even arrested. This causes hypoxia of cardiac cells associated with the deprivation of nutrients. In clinic, the first objective is to restore blood flow. However, this is associated with a burst in oxidation of cellular proteins and lipids. This oxidation enhances cell death and participates to the so-called reperfusion injury.
SANUWAVE Health, Inc. has entered into a two-year exclusive distribution agreement with CAN-med Healthcare, a division of IMP Group Limited, to distribute the Company's dermaPACE device throughout Canada.
University of Michigan researchers will use a new $1.6 million federal grant to probe potential social and environmental links to autism, collecting location-specific information from tens of thousands of affected individuals and their families nationwide.
KIYATEC, Inc researchers demonstrated that their immune-modified ex vivo platform can measure treatment response through direct interaction between a patient's cancer and infiltrating immune cells, and immuno-oncology agents.
› Verified 6 days ago
Colleen Straub, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Ericsson Dr Ste 100, Warrendale, PA 15086 Phone: 724-272-4509 | |
Kelsey Thompson, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 40 Pennwood Pl, Suite 300, Warrendale, PA 15086 Phone: 855-779-4720 Fax: 855-779-4721 | |
Jill A. Felicetti, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Ericsson Dr Ste 100, Warrendale, PA 15086 Phone: 724-772-6000 Fax: 901-435-4603 | |
Iris Rizk, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Ericsson Dr Ste 100, Warrendale, PA 15086 Phone: 724-772-6000 | |
Melissa Leigh Toy, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Ericsson Dr Ste 100su, Warrendale, PA 15086 Phone: 724-772-6000 | |
Mr. David Frank Senko, MS, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Ericsson Dr Ste 3000, Warrendale, PA 15086 Phone: 724-772-6000 |